Difficulty: Medium
Average Score: 95%
Practice
In which circumstance should a nurse avoid using midline and midclavicular sites for IV therapy?
Correct answer
B
Rationale
In pharmacology and nursing practice, the correct answer to the question is option B: To administer antineoplastic chemotherapy. This is because antineoplastic chemotherapy agents are highly vesicant and can cause tissue damage if they extravasate from the vein. Midline and midclavicular sites have a higher risk of extravasation due to the smaller veins and decreased blood flow compared to larger, more central veins like the subclavian or jugular veins.
Option A, administering solutions with a pH between 5 and 9, is not a reason to avoid midline and midclavicular sites. Veins in these locations can generally tolerate solutions within this pH range without significant irritation or damage.
Option C, administering slow, low-volume infusions, is typically suitable for midline and midclavicular sites as these veins are suitable for such infusions due to their accessibility and ease of monitoring.
Option D, administering solutions with an osmolality less than 500 mOsm/L, does not contraindicate the use of midline and midclavicular sites. These sites can generally accommodate solutions with osmolalities within this range without significant issues.
Educationally, understanding the appropriate site selection for IV therapy is crucial for nurses to ensure patient safety and optimal treatment outcomes. Utilizing central veins for vesicant medications like antineoplastic chemotherapy helps prevent serious complications such as tissue damage and necrosis. Nurses must continually assess and apply best practices in IV therapy to deliver safe and effective patient care.
Option A, administering solutions with a pH between 5 and 9, is not a reason to avoid midline and midclavicular sites. Veins in these locations can generally tolerate solutions within this pH range without significant irritation or damage.
Option C, administering slow, low-volume infusions, is typically suitable for midline and midclavicular sites as these veins are suitable for such infusions due to their accessibility and ease of monitoring.
Option D, administering solutions with an osmolality less than 500 mOsm/L, does not contraindicate the use of midline and midclavicular sites. These sites can generally accommodate solutions with osmolalities within this range without significant issues.
Educationally, understanding the appropriate site selection for IV therapy is crucial for nurses to ensure patient safety and optimal treatment outcomes. Utilizing central veins for vesicant medications like antineoplastic chemotherapy helps prevent serious complications such as tissue damage and necrosis. Nurses must continually assess and apply best practices in IV therapy to deliver safe and effective patient care.